Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Clinical Chemistry
Emerging Technology
Immunoassays
Molecular Diagnostics
Pathology & AI
PCR: Page 2
Qiagen launching syndromic molecular diagnostic system with respiratory panel in Japan
By
LabPulse.com staff writers
Qiagen said Monday that its QIAstat-Dx syndromic testing system is expected to be available soon in Japan with a SARS-CoV-2 Respiratory Panel that can detect more than 20 pathogens from a patient sample.
April 24, 2023
Curative spins off Sensible Diagnostics to commercialize point-of-care PCR platform
By
LabPulse.com staff writers
The spin-off is utilizing the experience Curative has gained with its diagnostics business during the pandemic, having run more than two million molecular point-of-care COVID-19 tests.
April 24, 2023
Seegene collaborates with Hy Laboratories, seeks similar deals to broaden syndromic testing
By
LabPulse.com staff writers
Embracing an open innovation model, the company is seeking leading companies to join a collaborative network and collectively develop hundreds, or more, of syndromic PCR assays annually to serve both local and global markets.
March 28, 2023
Long COVID less likely after Omicron than after original virus, Swiss researchers find
By
Elissa Wolfson
In a Swiss study, investigators have found that long COVID is less likely after Omicron infection than after infection by the original wild-type SARS-CoV-2 virus.
March 9, 2023
Servier, Qiagen partner to develop companion diagnostic test for AML
By
LabPulse.com staff writers
Under a master collaboration agreement, Qiagen will develop and validate a real-time PCR-based in vitro diagnostic test that can be used to detect IDH1 gene mutations in whole blood and bone marrow aspirates in AML.
March 9, 2023
Virufy nabs BARDA contract to develop cough- and speech-based COVID-19 detection technology
By
LabPulse.com staff writers
The project supports the firm’s aim to research and develop COVID-19 screening tools using artificial intelligence (AI)/machine learning (ML) technology.
March 8, 2023
Bio-Rad Laboratories revenue growth flat in Q4
By
LabPulse.com staff writers
Revenue increased almost 11% on a currency-neutral basis when COVID-related sales comparisons were excluded.
February 17, 2023
LumiraDx obtains FDA authorization for test to detect flu A, flu B, SARS-CoV-2
By
LabPulse.com staff writers
The test leverages a single-step direct method for nucleic acid extraction and amplification on validated open RT-PCR instruments.
February 7, 2023
Thermo Fisher Scientific obtains FDA EUA for monkeypox/orthopox virus DNA kit
By
LabPulse.com staff writers
The test is intended for the qualitative detection of DNA from monkeypox virus (clade I/II) and screening for non-variola orthopoxviruses in human lesion swab specimens.
December 15, 2022
BioGX launches portable qPCR platform with CE-IVD marked assays outside U.S.
By
LabPulse.com staff writers
The expanded availability of its products complements a recent FDA expanded Emergency Use Authorization for the Xfree COVID-19 Direct RT-PCR running on the portable PCR platform.
December 12, 2022
Cepheid says its influenza assays mitigate impact of mutational drift seen in some tests
By
LabPulse.com staff writers
Two mutations in the matrix genes of the human influenza A virus have been reported to cause matrix gene target failure for several commercial diagnostic tests.
December 8, 2022
Eurofins launches droplet digital PCR assay to detect SARS-CoV-2 variants of concern in wastewater
By
LabPulse.com staff writers
The assay detects Omicron subvariants BQ.1 and BQ.1.1, which currently make up more than 35% of the SARS-CoV-2 virus variant distribution in the U.S. and which are increasing at rates superseding all other current SARS-CoV-2 variants, the firm noted.
December 5, 2022
Previous Page
Page 2 of 23
Next Page
